Health ❯ Healthcare ❯ Clinical Trials

Randomized Controlled Trials

Patient Outcomes Efficacy Studies TARGET-D Trial Phase 3 Trials Meta-Analysis Intervention Studies EPIC-HR and EPIC-SR Trials Pain Relief Studies SOUL Trial Medication Effects Double-Blind Studies Neurodevelopmental Research Telehealth Studies AML17 and AML19 Trials Vaping Studies Sepsis Treatment Pain and Emotion Therapy Weight Loss Efficacy Drug Comparison Daratumumab Therapy PREDMETH Trial Exercise Intervention Medication Effectiveness Exercise and Cancer Intimate Partner Violence Research Transcranial Direct Current Stimulation (tDCS) TACSI Trial DETECT Hep C Trial Antiplatelet Therapy HAMD-17 Phase 3 Studies ACR Response Criteria Epcoritamab Study Beta-Blockers Long-term Use Assessment AQUATIC Trial Bronchoscopy Trials Pilot Studies TARGET-FIRST Trial DAPA ACT HF-TIMI 68 Colorectal Cancer Trials Trial Design TROPION-LUNG01 Trial ALASCCA Study Shunting for iNPH ASAP Study Pediatric Interventions ASAP Trial Pediatric Clinical Trials Efficacy Evaluation Meta-analysis Placebo-controlled Trials Participant Outcomes Clinical Practice Research Multicenter Trials TN-10 Study Herbal Medicine Yoga-Based Treatments Longitudinal Studies Multicenter Studies EQUAL Trial Reliability Studies AI in Clinical Trials BRAID Trial Systematic Reviews PRODROME Study Pain Management Hypertonic Saline Study Sulthiame in OSA Pharmacological Therapy

Evolocumab Cuts First Cardiovascular Events by 31% in High‑Risk Diabetes Without Known Atherosclerosis

The ACC 2026 analysis signals earlier, more aggressive LDL cholesterol lowering could reshape primary prevention for patients with diabetes.

Major Lancet Analysis Finds Most Statin Label Side Effects Not Caused by the Drugs

Oral Semaglutide Cuts Serious Heart-Failure Events 22% in Type 2 Diabetes With Heart Failure

Apple Watch Screening Quadruples AFib Detection in High-Risk Seniors, EQUAL RCT Finds

Bariatric Surgery’s Long-Term Edge Holds Across Social Vulnerability, ARMMS-T2D Analysis Finds

Shenzhuo Formula Improves Kidney Function Versus Irbesartan in 24-Week Diabetes Trial

Anti-Inflammatories Modestly Ease Depression for Patients With Elevated Inflammation, Meta-Analysis Finds

Meta-Analysis Finds GLP-1 Drugs Show Little Short-Term Impact on Obesity-Linked Cancer Risk

Epcoritamab Added to R2 Yields Large Efficacy Gains in Relapsed Follicular Lymphoma

EU Medicines Panel Backs Teizeild to Delay Type 1 Diabetes Onset

Real-World Study Finds Semaglutide and Tirzepatide Cut Cardiovascular Risk in Type 2 Diabetes

Personalized Vitamin D Strategy Halves Risk of Repeat Heart Attack in Randomized Trial

JAMA Meta-Analyses at Kidney Week Back Routine SGLT2 Inhibitors Across Kidney Function

AI App Matches Human-Led Diabetes Prevention in Phase 3 Trial

Simple Tools Boost Pediatricians’ Early Peanut Introduction Counseling in Randomized Trial

Long-Term ASAP Trial Finds Disease Risk, Not Remission, Drives AML Transplant Survival

Sham-Controlled Korean Trial Finds Low-Dose Radiotherapy Eases Knee Osteoarthritis Pain

Double-Blind Trial Confirms Shunt Surgery Improves Gait in Older Adults With Normal-Pressure Hydrocephalus

ESC Trials Recast Antiplatelet Strategies After PCI and CABG

Beta-Blockers After Heart Attack Show Mixed Results, Benefit Seen at 40–49% EF